{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Bristol Myers Squibb's Value Trap","slug":"bristol-myers-squibb-s-value-trap","published_at":"2026-06-02T04:02:28+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/bristol-myers-squibb-s-value-trap","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/145b272f-12b7-425d-8d9b-322f0820fa13.mp3","audio_url":"https://api.fastcast.ai/audio/145b272f-12b7-425d-8d9b-322f0820fa13.mp3","summary":"Bristol Myers Squibb looks like a bargain on paper with a low P/E and a juicy dividend, but looming patent expirations on key drugs could hurt profits. While the company has a proven track record and long-term potential, short-term revenue risks make it a risky play for quick gains. Best suited for patient investors willing to hold through the next decade. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/52909f8f2a0c4683","meta_description":"Bristol Myers Squibb looks like a bargain on paper with a low P/E and a juicy dividend, but looming patent expirations on key drugs could hurt profits. Wh…","key_points":[],"chapters":[],"topics":[],"duration_seconds":108,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/bristol-myers-squibb-s-value-trap/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/bristol-myers-squibb-s-value-trap.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}